PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33461297-1	2021	Recent data have shown anti-inflammatory effects for trans-resveratrol (RSV) and rosmarinic acid (RA) in various immune-competent cell models through reduction of lipopolysaccharide (LPS)-induced interleukin 6 (IL-6) release.	Resveratrol	53-70	interleukin 6	Homo sapiens	196-209	
33461297-1	2021	Recent data have shown anti-inflammatory effects for trans-resveratrol (RSV) and rosmarinic acid (RA) in various immune-competent cell models through reduction of lipopolysaccharide (LPS)-induced interleukin 6 (IL-6) release.	Resveratrol	53-70	interleukin 6	Homo sapiens	211-215	
33461297-1	2021	Recent data have shown anti-inflammatory effects for trans-resveratrol (RSV) and rosmarinic acid (RA) in various immune-competent cell models through reduction of lipopolysaccharide (LPS)-induced interleukin 6 (IL-6) release.	Resveratrol	72-75	interleukin 6	Homo sapiens	196-209	
33461297-6	2021	Next, the IL-6 modulatory effect of 100 muM RSV was studied in LPS-treated immune-competent HGF-1 cells.	Resveratrol	44-47	interleukin 6	Homo sapiens	10-14	
33461297-7	2021	After 6 h of treatment, RSV reduced the LPS-induced IL-6 gene expression and protein release by -46.2 +- 12.7 and -73.9 +- 2.99%, respectively.	Resveratrol	24-27	interleukin 6	Homo sapiens	52-56